| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $59.5M | -5.7% |
| R&D Expense | $24.7M | +38.6% |
| SG&A Expense | $58.8M | -1.1% |
| Operating Income | -$181.0M | -8577.0% |
| Interest Expense | $14.2M | +92.4% |
| Pre-tax Income | -$136.7M | -5117.8% |
| Income Tax | -$638K | -35.5% |
| Net Income | -$136.1M | -5093.4% |
| EPS (Basic) | -$5.00 | +7.9% |
| EPS (Diluted) | -$5.00 | +7.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $64.3M | — |
| Accounts Receivable | $533K | -72.5% |
| Current Assets | $74.5M | — |
| Total Assets | $205.4M | -20.8% |
| Current Liabilities | $56.9M | +4167.7% |
| Long-term Debt | $4.4M | — |
| Total Liabilities | $135.9M | +2394.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$132.5M | — |
| Capital Expenditures | $2.3M | +50.0% |
| Investing Cash Flow | -$3.4M | +98.7% |
| Financing Cash Flow | $138.2M | -46.9% |
| Free Cash Flow | -$134.8M | -5021.9% |
| Stockholders' Equity |
| $69.5M |
| +1479.3% |